Stock PLPL PLANDAÍ BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Plandaí Biotechnology, Inc.

Equities

PLPL

US72703D1000

Delayed OTC Markets
Other stock markets
 08:17:51 26/06/2024 pm IST 		5-day change 1st Jan Change
0.0003 USD 0.00% Intraday chart for Plandaí Biotechnology, Inc. 0.00% +50.00%
2023 Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC. CI
2023 Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.
CI
CapitalGainsReport: Penny Stock Breakout Watchlist (EPAZ, DPLS, PLPL, BDPT)
AQ
Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX)
AQ
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
AQ
CapitalGainsReport: News Catalysts Could Send These Stocks Soaring (EPAZ, GGSM, KYNC, PLPL)
AQ
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc
CI
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.
CI
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.
CI
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.
CI
Plandaí Biotechnology : Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
PU
Plandaí Biotechnology : SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
PU
Plandaí Biotechnology : Plandai Biotechnology, Inc. Reinstated
AQ
Plandai Biotechnology Provides Comment on SEC Action
GL
Plandaí Biotechnology Announces Successful Completion of Government Inspection of Affiliate Protext Pharma’s Proposed Medical Cannabis Facility
GL
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
GL
Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities
GL
Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential
GL
Plandai Biotechnology Discusses Potential for Using Phytofare in Treating Type II Diabetes
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLPL Stock
  4. News Plandaí Biotechnology, Inc.